We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+80.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.51B
AUM Growth
+$540M
Cap. Flow
-$18.6M
Cap. Flow %
-0.34%
Top 10 Hldgs %
46.25%
Holding
691
New
31
Increased
112
Reduced
426
Closed
60

Top Sells

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$36.2M
2
CLS icon
Celestica
CLS
+$21.9M
3
WMT icon
Walmart Inc
WMT
+$21.5M
4
UNH icon
UnitedHealth
UNH
+$20.7M
5
YUMC icon
Yum China
YUMC
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 48.98%
2 Communication Services 15.81%
3 Consumer Discretionary 13.07%
4 Healthcare 6.06%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XHR
476
Xenia Hotels & Resorts
XHR
$1.9B
$22.7K ﹤0.01%
1,658
-167
-9% -$2.27K
PEB icon
477
Pebblebrook Hotel Trust
PEB
$2.15B
$22.6K ﹤0.01%
1,987
-106
-5% -$1.14K
ALEX
478
DELISTED
Alexander & Baldwin
ALEX
$22K ﹤0.01%
1,212
-71
-6% -$1.3K
SYRE icon
479
Spyre Therapeutics
SYRE
$8.54B
$21.8K ﹤0.01%
1,299
-203
-14% -$3.31K
SPRY icon
480
ARS Pharmaceuticals
SPRY
$509M
$21.4K ﹤0.01%
2,126
-362
-15% -$5.2K
EYPT icon
481
EyePoint Inc
EYPT
$1.03B
$21.1K ﹤0.01%
1,483
-264
-15% -$3.04K
PGEN icon
482
Precigen
PGEN
$2.24B
$21.1K ﹤0.01%
6,411
-848
-12% -$2.39K
VRE
483
DELISTED
Veris Residential
VRE
$20.9K ﹤0.01%
1,377
-99
-7% -$1.47K
PRME icon
484
Prime Medicine
PRME
$527M
$20.8K ﹤0.01%
3,762
+404
+12% +$1.64K
TNGX icon
485
Tango Therapeutics
TNGX
$4.43B
$20.1K ﹤0.01%
2,394
-271
-10% -$1.83K
UMH
486
UMH Properties
UMH
$1.29B
$19.9K ﹤0.01%
1,343
-12
-0.9% -$192
URGN icon
487
UroGen Pharma
URGN
$1.86B
$19.9K ﹤0.01%
995
-85
-8% -$1.53K
SANA icon
488
Sana Biotechnology
SANA
$871M
$19.8K ﹤0.01%
5,566
-150
-3% -$542
SMA
489
SmartStop Self Storage REIT
SMA
$1.86B
$19.7K ﹤0.01%
+524
New +$19.1K
PGRE
490
DELISTED
Paramount Group
PGRE
$19.4K ﹤0.01%
2,968
-319
-10% -$2.12K
RLAY icon
491
Relay Therapeutics
RLAY
$4.1B
$19.4K ﹤0.01%
3,709
-577
-13% -$2.2K
DFTX
492
Definium Therapeutics
DFTX
$5.78B
$19.3K ﹤0.01%
1,637
-240
-13% -$2.24K
LEU icon
493
Centrus Energy
LEU
$3.48B
$19.2K ﹤0.01%
62
-4,000
-98% -$885K
TSHA icon
494
Taysha Gene Therapies
TSHA
$1.68B
$19.2K ﹤0.01%
5,869
+621
+12% +$1.76K
GERN icon
495
Geron
GERN
$828M
$18.8K ﹤0.01%
13,727
-1,753
-11% -$2.33K
ABUS icon
496
Arbutus Biopharma
ABUS
$857M
$18.7K ﹤0.01%
4,124
-728
-15% -$2.67K
CRMD icon
497
CorMedix
CRMD
$591M
$18.7K ﹤0.01%
1,606
+52
+3% +$629
ESRT icon
498
Empire State Realty Trust
ESRT
$872M
$18.7K ﹤0.01%
2,437
-108
-4% -$826
PDM
499
Piedmont Realty Trust
PDM
$1.21B
$18.6K ﹤0.01%
2,066
-154
-7% -$1.24K
RLJ icon
500
RLJ Lodging Trust
RLJ
$1.86B
$18.5K ﹤0.01%
2,573
-103
-4% -$776

Similar funds

GF Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, GF Fund Management held 691 positions worth $5.51B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q3 2025 filing shows 31 new, 112 increased, 426 reduced and 60 closed positions. Its largest new stake was Bloom Energy: 648,856 shares worth $54.9M. The largest sale was British American Tobacco, an estimated $36.2M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 46% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q3 2025 buy was Bloom Energy: 648,856 shares worth $54.9M.
  • GF Fund Management added most to Lumentum in Q3 2025, an estimated $33.3M increase.
  • GF Fund Management's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $36.2M.
  • GF Fund Management fully exited Yum China in Q3 2025, selling an estimated $14.8M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.51B portfolio in Q3 2025.
  • GF Fund Management opened 31 new positions and closed 60 in Q3 2025.
  • GF Fund Management's portfolio value rose 11% quarter-over-quarter to $5.51B.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.